Iatrogenic symptoms in otolaryngology.
D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000009:adverse effects; D000927:Anticonvulsants / Q000009:adverse effects; D000928:Antidepressive Agents / Q000009:adverse effects; D000959:Antihypertensive Agents / Q000009:adverse effects; D001285:Atropine / Q000009:adverse effects; D003276:Contraceptives, Oral / Q000009:adverse effects; D003638:Deafness / Q000139:chemically induced; D064420:Drug-Related Side Effects and Adverse Reactions; D004844:Epistaxis / Q000139:chemically induced; D005260:Female; D005984:Glutethimide / Q000009:adverse effects; D006801:Humans; D007049:Iatrogenic Disease; D008297:Male; D008750:Methyldopa / Q000009:adverse effects; D008875:Middle Aged; D008996:Monoamine Oxidase Inhibitors / Q000009:adverse effects; D009668:Nose Diseases / Q000139:chemically induced; D010038:Otorhinolaryngologic Diseases / Q000139:chemically induced*; D010612:Pharyngitis / Q000139:chemically induced; D012466:Salivary Gland Diseases / Q000139:chemically induced; D012852:Sinusitis / Q000139:chemically induced; D014012:Tinnitus / Q000139:chemically induced; D014717:Vertigo / Q000139:chemically induced
D000900:Anti-Bacterial Agents; D000927:Anticonvulsants; D000928:Antidepressive Agents; D000959:Antihypertensive Agents; D003276:Contraceptives, Oral; D008996:Monoamine Oxidase Inhibitors; D008750:Methyldopa; D001285:Atropine; D005984:Glutethimide